The publisher regrets that at the time this article was published Figure 2 was incorrect. The figure is now correct.
The publisher would like to apologise for any inconvenience caused.
. 2022 Apr 7;7(3):100472. doi: 10.1016/j.esmoop.2022.100472
Erratum to ‘Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival’
[ESMO Open Volume 7, Issue 2, April 2022, 100409]
F Miglietta
1, M Bottosso
1, G Griguolo
1,2, MV Dieci
1,2, V Guarneri
1,2,∗
F Miglietta
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
Find articles by F Miglietta
M Bottosso
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
Find articles by M Bottosso
G Griguolo
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
2Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
Find articles by G Griguolo
MV Dieci
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
2Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
Find articles by MV Dieci
V Guarneri
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
2Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
Find articles by V Guarneri
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova
2Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
∗
Correspondence to: Prof. Valentina Guarneri valentina.guarneri@unipd.it
Collection date 2022 Jun.
© 2022 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC9014390 PMID: 35398607
This corrects the article "Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival", 100409.